In short, the research showed that patients with type 2 diabetes or who were overweight/obese and taking GLP-1 receptor agonists were at a higher risk of developing NAION
GLP-1 therapy is generally a long-term maintenance strategy rather than a short-term solution
Compounded medications bypass insurance gatekeeping and prior authorization processes, enabling faster treatment initiation
For example, a 2019 study found that eating a whole avocado with a meal elevated levels of GLP-1 and peptide YY (another hormone tied to fullness), while also lowering insulin levels
In addition, several RCTs have shown that the DPP4i are also associated with lower insulin dose requirements [17,18,19]
[DOI] [PubMed] [Google Scholar] 67.Sindhvananda W., Poopuangpairoj W., Jaiprasat T., Ongcharit P